After analysis of The Cancer Genome Atlas cases, Ke et al. [48] and Wu et al. [49] identified RIMS2 as a prognostic gene for papillary thyroid carcinoma and lung adenocarcinoma patients, respectively. This evidence concerns the gene RIMS2 and thyroid gland papillary carcinoma.